CB1 cannabinoid receptors and on-demand defense against excitotoxicity

被引:969
作者
Marsicano, G
Goodenough, S
Monory, K
Hermann, H
Eder, M
Cannich, A
Azad, SC
Cascio, MG
Gutiérrez, SO
van der Stelt, M
López-Rodríguez, ML
Casanova, E
Schütz, G
Zieglgänsberger, W
Di Marzo, V
Behl, C
Lutz, B
机构
[1] Max Planck Inst Psychiat, Clin Neuropharmacol Grp, D-80804 Munich, Germany
[2] Johannes Gutenberg Univ Mainz, Inst Physiol Chem & Pathobiochem, D-55099 Mainz, Germany
[3] Univ Munich, Klinikum Grosshadern, Clin Anaesthesiol, D-81377 Munich, Germany
[4] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, I-80078 Naples, Italy
[5] Univ Complutense, Dept Organ Chem, E-28040 Madrid, Spain
[6] German Canc Res Ctr, Div Mol Biol Cell 1, D-69120 Heidelberg, Germany
关键词
D O I
10.1126/science.1088208
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Abnormally high spiking activity can damage neurons. Signaling systems to protect neurons from the consequences of abnormal discharge activity have been postulated. We generated conditional mutant mice that lack expression of the cannabinoid receptor type 1 in principal forebrain neurons but not in adjacent inhibitory interneurons. In mutant mice, the excitotoxin kainic acid (KA) induced excessive seizures in vivo. The threshold to KA-induced neuronal excitation in vitro was severely reduced in hippocampal pyramidal neurons of mutants. KA administration rapidly raised hippocampal levels of anandamide and induced protective mechanisms in wild-type principal hippocampal neurons. These protective mechanisms could not be triggered in mutant mice. The endogenous cannabinoid system thus provides on-demand protection against acute excitotoxicity in central nervous system neurons.
引用
收藏
页码:84 / 88
页数:5
相关论文
共 40 条
[1]   Endocannabinoids control spasticity in a multiple sclerosis model [J].
Baker, D ;
Pryce, G ;
Croxford, JL ;
Brown, P ;
Pertwee, RG ;
Makriyannis, A ;
Khanolkar, A ;
Layward, L ;
Fezza, F ;
Bisogno, T ;
Di Marzo, V .
FASEB JOURNAL, 2001, 15 (02) :300-302
[2]   Kainate, a double agent that generates seizures: two decades of progress [J].
Ben-Ari, Y ;
Cossart, R .
TRENDS IN NEUROSCIENCES, 2000, 23 (11) :580-587
[3]   Excitatory actions of GABA during development: The nature of the nurture [J].
Ben-Ari, Y .
NATURE REVIEWS NEUROSCIENCE, 2002, 3 (09) :728-739
[4]  
Cadas H, 1996, J NEUROSCI, V16, P3934
[5]   A CamKIIα iCre BAC allows brain-specific gene inactivation [J].
Casanova, E ;
Fehsenfeld, S ;
Mantamadiotis, T ;
Lemberger, T ;
Greiner, E ;
Stewart, AF ;
Schütz, G .
GENESIS, 2001, 31 (01) :37-42
[6]   Hippocampal neurotoxicity of Δ9-tetrahydrocannabinol [J].
Chan, GCK ;
Hinds, TR ;
Impey, S ;
Storm, DR .
JOURNAL OF NEUROSCIENCE, 1998, 18 (14) :5322-5332
[7]   GLUTAMATE NEUROTOXICITY AND DISEASES OF THE NERVOUS-SYSTEM [J].
CHOI, DW .
NEURON, 1988, 1 (08) :623-634
[8]  
Clement AB, 2003, J NEUROSCI, V23, P3916
[9]   OXIDATIVE STRESS, GLUTAMATE, AND NEURODEGENERATIVE DISORDERS [J].
COYLE, JT ;
PUTTFARCKEN, P .
SCIENCE, 1993, 262 (5134) :689-695
[10]   Therapeutic potential of cannabinoids in CNS disease [J].
Croxford, JL .
CNS DRUGS, 2003, 17 (03) :179-202